Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 1.3T | 1.3T | 1.8T | 1.5T |
Cost of revenue | 1.1T | 1.0T | 1.5T | 1.2T |
Gross profit | 279.3B | 241.7B | 330.2B | 283.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 52.9B | 51.3B | 34.3B | 43.3B |
Other operating expenses | 3.3B | 4.1B | 886M | 1.6B |
Operating income | 219.7B | 173.7B | 285.2B | 237.5B |
Non operating interest income | ||||
Income | 5.7B | 5.7B | 1B | 70M |
Expense | 56.7B | 47.8B | -5.4B | 54.7B |
Other income expense | — | — | — | — |
Pretax income | 162.3B | 105.5B | 219.9B | 189.2B |
Tax provision | 33.5B | 21.0B | 47.9B | 40.7B |
Net income | 128.8B | 84.5B | 172.0B | 148.5B |
Basic EPS | — | 12.0 | — | — |
Diluted EPS | — | 12.0 | — | — |
Basic average shares | — | 7.1B | — | — |
Diluted average shares | — | 7.1B | — | — |
EBITDA | 222.6B | 156.7B | 222.9B | 249.7B |
Net income from continuing op. | — | — | — | — |
Minority interests | 7M | 8M | 9M | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |